Skip to content

Clinical trials

Phase 2 Glaucoma, Open-Angle trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glaucoma, Open-Angle Phase: Phase 2 Clear all

106 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20051
20064
20078
20087
20096
20105
20117
20126
20137
20147
20153
20165
20174
20181
20193
20204
20215
20222
20234
20244
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed91
Unknown status5
Terminated4
Recruiting2
Active, not recruiting2
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alcon Research23
Aerie Pharmaceuticals10
Santen Inc.6
Glaukos Corporation5
Allergan4
ForSight Vision5, Inc.4
Mati Therapeutics Inc.4
Qlaris Bio, Inc.4
Bausch & Lomb Incorporated3
Chong Kun Dang Pharmaceutical2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glaucoma, Open-Angle106
Ocular Hypertension86
Glaucoma34
Hypertension4
Low Tension Glaucoma3
Cataract1
Diabetic Retinopathy1
Exfoliation Syndrome1
Eye Diseases1
Glaucoma, Neovascular1

Trials

Showing 26 to 50 of 106. Each trial links to its page on Pharma Observatory.

6 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.